Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus
Additional supplements can be added gradually if needed over time
Additionally, microglia, which are primary targets of the GLP-1R signal transduction pathway in the spinal cord, exhibit reduced activation and decreased expression of pro-inflammatory cytokines following exendin-4 treatment, suggesting therapeutic potential in monophasic EAE [113]
How Triple Agonism Differs Pharmacologically The research appeal of triple agonists like retatrutide lies in the combination of three biological effects: GLP-1 receptor activation: Increased insulin secretion (glucose-dependent), reduced glucagon secretion, delayed gastric emptying, appetite reduction
GI effects dominate: nausea (35-60%), diarrhea (20-40%), vomiting (~20%), and constipation (20-30%) at higher doses
If you are still deciding whether this kind of treatment fits your goals, you can take the free assessment quiz to see whether a personalized program is the right next step
